Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was deleted on the site.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2 label.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 was added, and the previous notices about government funding lapses and NIH operating status were removed. These are administrative site updates and do not change the study details or functionality presented on the page.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded a government funding lapse notice at the top of the page with guidance and links to cc.nih.gov and opm.gov, and updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check68 days agoChange DetectedShow glossary added to the page. The QC-related labels were updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision version was bumped to v3.4.0 from v3.3.4.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4; no observable changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.